Results for tag: "Pyrrobutamine"

Pyrrobutamine is a respiratory drug used to treat bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It is a long-acting beta-2 agonist (LABA) that works by relaxing the muscles of the airways, allowing more air to flow in and out of the lungs. Pyrrobutamine is available in both oral and inhaled forms, and is often used in combination with other medications to provide better symptom control. It is generally well-tolerated, but can cause side effects such as headache, nausea, and dizziness. The Pyrrobutamine market is a competitive one, with a number of companies offering products. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies offer a range of products, including inhalers, tablets, and solutions, to meet the needs of different patients. Show Less Read more